Skip to main content

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New procedure and diagnostic codes added to the private reimbursement schedule in England

23 Aug 2023

On August 10, 2023, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 191 and 087 with changes to be implemented no later than October 6, 2023

Four new codes concerning urogynecology procedures were introduced. Some examples are provided below:

  • P2430 Robotic assisted laparoscopic sacrocolpopexy +/- ureterolysis, using mesh;
  • P2432 Sacrocolpopexy (including laparoscopic) +/- ureterolysis, using mesh.

Furthermore, one new procedure code was added in the neuromodulation field. 

Six new codes were introduced for in-vitro diagnostic tests. As an example, 0046G “MRD Genomic Sequencing Solid Tumours”.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.